The Cells From Your Mother That May Stay Inside You for Decades
For most of us, the physical connection between mother and child seems to end at birth.
The umbilical cord is cut. The placenta is delivered. The newborn begins an independent life.
But biology is not quite that tidy.
During pregnancy, cells can cross the placenta in both directions. Some cells from the developing fetus enter the mother’s circulation, while maternal cells can enter the fetus.
Some of those maternal cells can remain in the child long after birth.
The phenomenon is called maternal microchimerism, and scientists are now discovering just how persistent and biologically interesting it may be.
For older adults looking back over decades of life, the finding adds an extraordinary dimension to the story of pregnancy: a pregnancy may leave behind a microscopic cellular legacy that can potentially remain long after childhood.
What exactly is maternal microchimerism?
The word sounds complicated, but the basic idea is surprisingly simple.
A person can carry a very small population of cells that originated from another genetically distinct person.
During pregnancy, maternal cells can cross the placenta and enter the developing fetus. Researchers have subsequently identified maternal cells in different tissues of children and adults, including the heart, liver, lungs and brain. Reviews of the evidence report that these cells can persist for many years and sometimes decades.
The number of cells is tiny compared with the person’s own cells.
But their rarity does not necessarily make them biologically irrelevant.
Researchers are investigating whether some maternal cells can interact with the immune system, occupy particular tissue environments and potentially adopt characteristics of local cells.
That is where the story becomes much more complicated.
Your mother may have left a cellular trace—not a second genome
Microchimerism does not mean that a person has two complete genomes throughout the body.
The vast majority of cells still carry the person’s own genetic identity.
Instead, microchimerism refers to a small population of genetically different cells living within the larger population of the host’s cells.
Recent research has made the phenomenon particularly interesting in the human brain.
A 2026 study examining human brain tissue reported maternal microchimerism in 70% of the epilepsy specimens studied and found evidence of maternal cells across several brain regions. The researchers also analyzed brain datasets spanning development through late adulthood and reported evidence of maternal microchimerism persisting into advanced age.
That does not mean that everyone’s brain contains a known quantity of maternal cells, nor does it prove that those cells influence memory, personality or intelligence.
It does, however, make the brain another place where scientists are investigating the long-term consequences of maternal-fetal cell exchange.
What might these cells actually be doing?
This is where the science becomes fascinating—and uncertain.
Researchers have proposed several possibilities.
Some maternal microchimeric cells appear to have immune functions. Others may show characteristics associated with different tissue types.
Scientists have also investigated whether microchimeric cells respond to tissue injury or participate in repair processes. Reviews describe evidence suggesting possible regenerative effects, while emphasizing that the precise mechanisms and health consequences remain unresolved.
One possibility is that these cells are largely harmless passengers.
Another is that they can become useful under particular circumstances.
A third possibility is that they may sometimes contribute to inflammation or autoimmune disease.
The answer may ultimately be all three, depending on the tissue, the person’s immune system and the circumstances.
The autoimmune connection
Microchimerism has attracted considerable attention from immunologists because some studies have found associations between maternal cells and autoimmune conditions.
Researchers have investigated maternal microchimerism in diseases including systemic sclerosis and other autoimmune disorders. But finding maternal cells in diseased tissue does not automatically demonstrate that those cells caused the disease.
This distinction matters.
Autoimmune diseases have complicated causes involving genetics, immune regulation, hormones and environmental influences.
Maternal microchimerism may be one factor in some situations, but current research does not justify saying that a mother’s cells cause autoimmune disease.
In fact, researchers are also investigating potentially beneficial roles.
Could these cells help repair damaged tissue?
This is one of the most intriguing possibilities.
Scientists have found microchimeric cells in areas of tissue injury and have proposed that some may participate in repair or regeneration.
A review of fetomaternal microchimerism describes evidence linking these cells with tissue-repair responses, while noting that researchers still need to establish whether the cells actually improve tissue function in humans.
That leaves an important question unanswered:
Are these cells active repair workers—or simply cells that happen to gather where injury has occurred?
At present, scientists cannot give a definitive answer.
That uncertainty is one reason microchimerism remains such an active field of research.
Why the discovery matters more as we age
For older adults, the research has a broader lesson.
Many biological processes that begin before birth may continue influencing the body decades later.
Scientists are increasingly interested in how early-life exposures, immune development and long-term inflammation shape health across the lifespan.
Maternal microchimerism adds another layer to that picture.
It suggests that pregnancy can leave behind a population of genetically distinct cells that remains detectable long after the pregnancy itself has become a distant memory.
But there is currently no clinical test recommended for healthy older adults simply to determine whether maternal microchimeric cells are present, and there is no established treatment designed to increase or eliminate them.
This is fundamental biological research—not a new medical screening recommendation.
The mystery is what comes next
The most exciting question may not be whether your mother’s cells can remain inside you.
Researchers increasingly have evidence that they can.
The harder question is what they do once they get there.
Do they quietly coexist with your own cells?
Do they influence immune responses?
Can some contribute to tissue repair?
Could they affect susceptibility to particular diseases?
And why do some cells persist for decades while others disappear?
Scientists are still working through those questions.
Recent expert discussions have emphasized major gaps in the field, including how microchimeric cells should be detected, how their functions should be studied and how researchers can distinguish genuine biological effects from simple associations.
For now, the safest conclusion is also the most remarkable one.
The biological separation between mother and child may not be as complete as we once imagined.
During pregnancy, cells cross the boundary between two bodies.
Some may remain for decades.
And long after the umbilical cord has been cut, scientists are discovering that a tiny cellular reminder of that first relationship may still be present—quietly embedded in the biology of the person who grew from it.
The mystery is no longer whether the cells can stay.
It is what they have been doing all this time.
Photo by Yan Krukau: https://www.pexels.com/photo/happy-mother-holding-in-arms-small-baby-5789190/
About Wellcore Weekly: Wellcore Weekly covers health, wellness, nutrition, sleep, fitness, and medical research with timely, easy-to-understand updates for everyday readers.
